We have collected information about Drug Delivery Expert Opinion for you. Follow the links to find out details on Drug Delivery Expert Opinion.
https://www.tandfonline.com/loi/iedd20
Browse the list of issues and latest articles from Expert Opinion on Drug Delivery. List of issues Latest articles Partial Access; Volume 17 2020 Volume 16 2019 Volume 15 2018 Volume 14 2017 Volume 13 2016 Volume 12 2015 Volume 11 2014 Volume 10 2013 …
https://www.ncbi.nlm.nih.gov/labs/journals/expert-opin-drug-deliv/
G Ahmad et al. Expert Opin Drug Deliv 1-12. 2016 Dec 01. Cancer initiating or stem cells (CSCs) are a small population of cells in the tumor mass, which have been reported to be present in different types of cancers. CSCs usually reside within the tumor and are responsible for reoccurrence of cancer.
https://www.tandfonline.com/toc/iedd20/current
Expert Opinion on Drug Delivery 2018 Impact Factor 5.400 Providing comprehensive coverage of drug delivery research, including delivery technologies, vehicles, formulations and devices, the delivery of specific drug and therapeutic classes, modes of entry into the body, and applications in diseases.
https://www.tandfonline.com/doi/abs/10.1080/17425247.2019.1556257
Dec 03, 2018 · Expert opinion: The introducing the GO amends the mechanical characteristics of CS, which is a major problem in the use of CS-based carriers in drug delivery due to burst release in a CS-based controlled release system through the poor mechanical strength of CS. Many related research on this area are still not fully unstated and occasionally ...Author: Sahar Gooneh-Farahani, M. Reza Naimi-Jamal, Seyed Morteza Naghib
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163784/
Expert Opinion Section It is clear that standard chemotherapeutics, given via standard routes of administration, have reached their limits for improving outcomes in osteosarcoma. Over the last two decades, multiple clinical trials have evaluated more intensive chemotherapy protocols and the addition of different or additional agents, with only modest improvements in event-free and overall survival.Author: Dennis Pm Hughes
https://www.tandfonline.com/doi/abs/10.1517/17425247.2016.1125880
Dec 14, 2015 · Expert opinion: There have been many different approaches to developing the delivery system of anticoagulants. One approach has been to expand the use of new oral agents and develop their antidotes. Reducing the size of heparins to use smaller heparins for delivery, and developing oral or topical heparins are also some of the approaches used.Author: Jooho Park, Youngro Byun
Searching for Drug Delivery Expert Opinion?
You can just click the links above. The data is collected for you.
